Steven Rosenberg, MD
Allergy & Immunology · Altamonte Springs, FLNPI 1245225630
Payments from drug & device makers
Across 388 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Novartis$1K
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$812
- Sanofi$582
- Optinose US, Inc.$575
- plus $3K from 30 others
What the payments were for
- Food & beverage$7,51889%
- Education$581%
- Gifts$91111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 88 | $1,466 |
| Novartis | 21 | $1,301 |
| AstraZeneca | 52 | $1,129 |
| Regeneron Healthcare Solutions, Inc. | 38 | $812 |
| Sanofi | 27 | $582 |
| Optinose US, Inc. | 31 | $575 |
| Pfizer | 17 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $346 |
| Teva Pharmaceuticals USA, Inc. | 15 | $266 |
| Genentech USA, Inc. | 19 | $259 |
| Sun Pharmaceutical Industries Inc. | 8 | $239 |
| Amgen | 5 | $117 |
| Grifols USA, LLC | 6 | $103 |
| Aimmune Therapeutics, Inc. | 5 | $97 |
| Sanofi-aventis U.S. LLC | 2 | $94 |
| Pharming Healthcare, Inc. | 4 | $88 |
| AbbVie | 4 | $82 |
| Kaleo, Inc. | 4 | $60 |
| Boehringer Ingelheim | 3 | $58 |
| Hikma Pharmaceuticals USA | 3 | $50 |
| Covis Pharma GmbH | 2 | $44 |
| CSL Behring | 1 | $36 |
| Merck | 2 | $31 |
| Alk-abello, Inc | 2 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Sunovion Pharmaceuticals Inc. | 2 | $28 |
| Greer Laboratories, Inc. | 1 | $25 |
| Biocryst US Sales Co., LLC | 1 | $25 |
| Biofrontera Inc. | 1 | $20 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| USWM, LLC | 1 | $19 |
| Shire North American Group Inc | 1 | $16 |
| LEO Pharma Inc. | 1 | $16 |
| Electromed, Inc. | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Biogen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GILENYA$890
- FASENRA$125
- TRELEGY ELLIPTA$111
- NUCALA$103
How this compares
$8,487 in reported general payments places this provider in the 55th percentile of 204 allergy & immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 148 | $128,331 |
| Dupixent SyringeDupilumab | 19 | $85,070 |
| Breo ElliptaFluticasone/Vilanterol | 40 | $15,993 |
| Advair HfaFluticasone Propion/Salmeterol | 25 | $10,398 |
| Arnuity ElliptaFluticasone Furoate | 25 | $5,279 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 115 | $2,941 |
| Levocetirizine Dihydrochloride | 125 | $1,569 |
| Ventolin HfaAlbuterol Sulfate | 15 | $1,102 |
| Montelukast Sodium | 118 | $1,033 |
| Fluticasone Propionate | 112 | $1,020 |
| Azelastine Hcl | 43 | $846 |
| Triamcinolone Acetonide | 20 | $265 |
| Cyproheptadine Hcl | 17 | $155 |
| Famotidine | 29 | $150 |
| Azithromycin | 32 | $126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,466 | $149,603213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 204 allergy & immunology providers in Florida.
Other allergy & immunology in Altamonte Springs
- Andrew BaggAltamonte Springs$113K
- Pragnesh PatelAltamonte Springs$84K
- Warit JithpratuckAltamonte Springs$24K
- Jaime LandmanAventura$3.9M
- Ileana RodicioMiami$3.8M
- Jose CarpioMiami$3.6M
- Michael KohenDaytona Beach$3.6M
- Thomas CasaleTampa$1.7M
- Dennis LedfordTampa$1.4M
- Ronald SaffTallahassee$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.